Why the study?
Does elevated preoperative HMGB1 predict myocardial injury and worse clinical outcomes in patients undergoing percutaneous coronary intervention?
Does elevated preoperative HMGB1 predict myocardial injury and worse clinical outcomes in patients undergoing percutaneous coronary intervention?
Elevated preoperative HMGB1 levels may serve as a useful biomarker to predict post-PCI myocardial injury and worse 1-year clinical outcomes.
In this study, we evaluated the impact of preoperative high mobility group box 1 (HMGB1) on myocardial injury post-percutaneous coronary intervention.We evaluated 302 consecutive patients who underwent percutaneous coronary intervention. They were divided into equal tertiles based on their preoperative HMGB1 levels. Creatine kinase-MB and troponin I levels were measured at baseline, 8- and 24-hours after the procedure, while clinical outcomes were followed up for 1 year.The occurrence of post-procedural myocardial injury was significantly higher in the tertile comprising of patients with elevated HMGB1 levels. Moreover, these patients showed significantly higher post-procedural peak values of creatine kinase-MB and troponin I in comparison to patients with lower HMGB1 levels. Event-free survival was significantly associated with HMGB1 levels, with worst event-free survival in patients with elevated HMGB1 levels.Elevated preoperative HMGB1 was a predictor of myocardial injury after percutaneous coronary intervention, and was associated with the worst clinical outcomes during 1-year follow up.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: